Veristat and TCTC Group Join to Strengthen Global Presence

Veristat Acquires TCTC Group Increasing Its European Footprint and Expanding Therapeutic Expertise to Guide Sponsors Throughout the Clinical Development Lifecycle

Landing Page Header Image-1

The acquisition of The Clinical Trial Company Ltd. (TCTC Group) harnesses complementary strengths, expertise, and scale to provide superior solutions and progressive approaches to mitigate risk and achieve meaningful outcomes for sponsors and their patients globally. Through expanding our full-service offering in Europe, we'll bring new options to both existing and new clients.

Veristat, a full-service CRO has acquired TCTC Group to strengthen its service and therapeutic capabilities. TCTC Group contributes a wealth of experience in gene and cell therapy, CNS and orphan disease trials; providing high-quality clinical research services to companies operating in these areas. Additionally, TCTC Group brings knowledge and experience in advising clients on trial strategies in advanced therapies.  Both Veristat and TCTC Group clients will benefit from the collective expertise and capabilities offered by this superior team of senior clinical experts.  

Learn More About 
Veristat & TCTC Group

Want to know when, why and how Veristat acquired TCTC Group?  

Read the full press release.  

Read Press Release


Explore how our team of clinical experts can guide you through the design, start-up and management of your clinical trials to their successful completion.  We’ve assembled a premier regulatory affairs, operations, and consulting team. 

Learn more about our clinical operations service offerings.

Clinical Operations Services


TCTC customers now have access to the full suite of Veristat clinical, medical, biometrics, medical writing and regulatory support solutions.   Leverage our cross-functional team to advance your medical therapies through all phases of clinical development to market launch and beyond.  

Explore how we can support you.

Explore Services Offerings




Have An Integration Question?  Ask Us Now

Request A Proposal